ORP — Orpea SA Share Price
Last trade - 00:00- €1.95bn
- €1.43bn
- €5.20bn
- 12
- 38
- 17
- 11
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.4 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -223.33% | ||
| Operating Margin | -85.29% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 3,740.22 | 3,922.39 | 4,298.57 | 4,680.9 | 5,198 | 5,324.5 | 5,937 | 8.73% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -2.98 | -36.23 | -43.94 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Orpea SA is a France-based company that is engaged in the operations of retirement homes, outpatient and rehabilitation clinics, and psychiatric care. Through its wholly owned subsidiary, Clinea, the Company also offers a range of other services, from outpatient treatment, post-operation care and physical therapy, to nursing, geriatric care, psychiatric services, and long-term care homes. The Company operates a number of wholly owned subsidiaries, including Clinea, Villers Services SA, Residence La Cheneraie SAS, Carina SA, Super Aix SCI, Emcejidey SA, Maison de Retraite Paul Cezanne SA and Inoges AG, among others. It operates through Vitalis, Senevita, Dr. Dr. Wagner group and Anavita, operator of nursing homes in the Czech Republic.
Directors
- Philippe Charrier CHM (67)
- Yves Le Masne CEO (58)
- Sophie Kalaidjian DRC (43)
- Laurent Serris DRC (51)
- Laure Baume IND (45)
- Bernadette Danet-Chevallier IND (62)
- Corine De Bilbao IND (54)
- Jean-Patrick Fortlacroix IND (63)
- Moritz Krautkramer IND (40)
- Olivier Lecomte IND (55)
- Thierry Mabille de Poncheville IND (65)
- Pascale Richetta IND (62)
- Joy Verle IND (42)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2023
- Incorporated
- May 22nd, 1995
- Public Since
- April 16th, 2002
- No. of Employees
- 76,160
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 159,191,656
- Address
- 12 Rue Jean Jaures, Puteaux Cedex, PUTEAUX, 92813
- Web
- https://www.orpea.com/
- Phone
- +33 147757807
- Auditors
- Deloitte & Associes
Latest News for ORP
Upcoming Events for ORP
Q1 2024 Orpea SA Corporate Sales Release
Full Year 2023 Orpea SA Earnings Release
Half Year 2024 Orpea SA Earnings Release
Q2 2024 Orpea SA Corporate Sales Release
Similar to ORP
Bastide le Confort Medical SA
Euronext - Paris
Clariane SE
Euronext - Paris
Eurofins Scientific SE
Euronext - Paris
LNA Sante SA
Euronext - Paris
Ramsay Generale De Sante SA
Euronext - Paris
FAQ
As of Today at 19:16 UTC, shares in Orpea SA are trading at €12.25. This share price information is delayed by 15 minutes.
Shares in Orpea SA last closed at €12.25 and the price had moved by -94.2% over the past 365 days. In terms of relative price strength the Orpea SA share price has underperformed the FTSE Global All Cap Index by -94.55% over the past year.
The overall consensus recommendation for Orpea SA is Sell. You can view the full broker recommendation list by unlocking its StockReport.
Orpea SA does not currently pay a dividend.
Orpea SA does not currently pay a dividend.
Orpea SA does not currently pay a dividend.
To buy shares in Orpea SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €12.25, shares in Orpea SA had a market capitalisation of €1.95bn.
Here are the trading details for Orpea SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ORP
Based on an overall assessment of its quality, value and momentum Orpea SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Orpea SA is €166.60. That is 1260% above the last closing price of €12.25.
Analysts covering Orpea SA currently have a consensus Earnings Per Share (EPS) forecast of -€16.98 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Orpea SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -86.22%.
As of the last closing price of €12.25, shares in Orpea SA were trading -83% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Orpea SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €12.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Orpea SA's management team is headed by:
- Philippe Charrier - CHM
- Yves Le Masne - CEO
- Sophie Kalaidjian - DRC
- Laurent Serris - DRC
- Laure Baume - IND
- Bernadette Danet-Chevallier - IND
- Corine De Bilbao - IND
- Jean-Patrick Fortlacroix - IND
- Moritz Krautkramer - IND
- Olivier Lecomte - IND
- Thierry Mabille de Poncheville - IND
- Pascale Richetta - IND
- Joy Verle - IND